Eribulin in metastatic breast cancer: Real world data
CONCLUSIONS: The median PFS was similar to that reported previously, with lower OS. There was a tendency to achieve better results when eribulin was used earlier. Eribulin is a less well-tolerated drug than published literature.PMID:38073367 | DOI:10.3233/BD-230031 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Clara Luz Fern ández-Laguna Ivan Maray Lola Macia-Rivas Cristina Álvarez-Asteinza Sergio Fern ández-Lastras Veronica Velasco Dur ántez M ónica Carbajales Álvarez Ana Lozan-Bl ázquez Source Type: research
Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences
CONCLUSION: Customized external breast prostheses could be an alternative to the conventional ones for breast cancer patients with mastectomy, with additional benefits of less sweating, more comfort and less dislodgement perceived.PMID:38073368 | DOI:10.3233/BD-230040 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Ruey Pyng Ng John C Allen Yen-Yen Chia Geok Hoon Lim Source Type: research
Can paternal environmental experiences affect the breast cancer risk in offspring? A systematic review
CONCLUSION: Studies considered in this article show that fathers' age at the time of delivery of the child, dietary habits, overweight and occupational factors can affect the incidence of BC risk in the next generation.PMID:38073366 | DOI:10.3233/BD-220062 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Najmeh Bagher Hosseini Sara Moosapour Haniyeh Bashi Zadeh Fakhar Afshin Ryan Nazari Maryam Omrani Hasehmi Fatemeh Hadavand Mohammad Seraj Mohammad-Esmaiel Akbari Source Type: research
Eribulin in metastatic breast cancer: Real world data
CONCLUSIONS: The median PFS was similar to that reported previously, with lower OS. There was a tendency to achieve better results when eribulin was used earlier. Eribulin is a less well-tolerated drug than published literature.PMID:38073367 | DOI:10.3233/BD-230031 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Clara Luz Fern ández-Laguna Ivan Maray Lola Macia-Rivas Cristina Álvarez-Asteinza Sergio Fern ández-Lastras Veronica Velasco Dur ántez M ónica Carbajales Álvarez Ana Lozan-Bl ázquez Source Type: research
Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences
CONCLUSION: Customized external breast prostheses could be an alternative to the conventional ones for breast cancer patients with mastectomy, with additional benefits of less sweating, more comfort and less dislodgement perceived.PMID:38073368 | DOI:10.3233/BD-230040 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Ruey Pyng Ng John C Allen Yen-Yen Chia Geok Hoon Lim Source Type: research
Can paternal environmental experiences affect the breast cancer risk in offspring? A systematic review
CONCLUSION: Studies considered in this article show that fathers' age at the time of delivery of the child, dietary habits, overweight and occupational factors can affect the incidence of BC risk in the next generation.PMID:38073366 | DOI:10.3233/BD-220062 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Najmeh Bagher Hosseini Sara Moosapour Haniyeh Bashi Zadeh Fakhar Afshin Ryan Nazari Maryam Omrani Hasehmi Fatemeh Hadavand Mohammad Seraj Mohammad-Esmaiel Akbari Source Type: research
Eribulin in metastatic breast cancer: Real world data
CONCLUSIONS: The median PFS was similar to that reported previously, with lower OS. There was a tendency to achieve better results when eribulin was used earlier. Eribulin is a less well-tolerated drug than published literature.PMID:38073367 | DOI:10.3233/BD-230031 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Clara Luz Fern ández-Laguna Ivan Maray Lola Macia-Rivas Cristina Álvarez-Asteinza Sergio Fern ández-Lastras Veronica Velasco Dur ántez M ónica Carbajales Álvarez Ana Lozan-Bl ázquez Source Type: research
Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences
CONCLUSION: Customized external breast prostheses could be an alternative to the conventional ones for breast cancer patients with mastectomy, with additional benefits of less sweating, more comfort and less dislodgement perceived.PMID:38073368 | DOI:10.3233/BD-230040 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Ruey Pyng Ng John C Allen Yen-Yen Chia Geok Hoon Lim Source Type: research
Can paternal environmental experiences affect the breast cancer risk in offspring? A systematic review
CONCLUSION: Studies considered in this article show that fathers' age at the time of delivery of the child, dietary habits, overweight and occupational factors can affect the incidence of BC risk in the next generation.PMID:38073366 | DOI:10.3233/BD-220062 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Najmeh Bagher Hosseini Sara Moosapour Haniyeh Bashi Zadeh Fakhar Afshin Ryan Nazari Maryam Omrani Hasehmi Fatemeh Hadavand Mohammad Seraj Mohammad-Esmaiel Akbari Source Type: research
Eribulin in metastatic breast cancer: Real world data
CONCLUSIONS: The median PFS was similar to that reported previously, with lower OS. There was a tendency to achieve better results when eribulin was used earlier. Eribulin is a less well-tolerated drug than published literature.PMID:38073367 | DOI:10.3233/BD-230031 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Clara Luz Fern ández-Laguna Ivan Maray Lola Macia-Rivas Cristina Álvarez-Asteinza Sergio Fern ández-Lastras Veronica Velasco Dur ántez M ónica Carbajales Álvarez Ana Lozan-Bl ázquez Source Type: research
Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences
CONCLUSION: Customized external breast prostheses could be an alternative to the conventional ones for breast cancer patients with mastectomy, with additional benefits of less sweating, more comfort and less dislodgement perceived.PMID:38073368 | DOI:10.3233/BD-230040 (Source: Breast Disease)
Source: Breast Disease - December 11, 2023 Category: Cancer & Oncology Authors: Ruey Pyng Ng John C Allen Yen-Yen Chia Geok Hoon Lim Source Type: research
Genomic analysis of breast cancer patients from Kerala: A novel BRCA1 mutation detected
CONCLUSION: In the present study, out of four detected mutations in the BRCA1 gene, three were known and one was a novel BRCA1 mutation. It is advised to perform NGS-based genome sequencing to identify the genetic predisposition in breast cancer patients.PMID:37980640 | DOI:10.3233/BD-220002 (Source: Breast Disease)
Source: Breast Disease - November 19, 2023 Category: Cancer & Oncology Authors: Adarsh Dharmarajan Vipin Gopinath Sangeetha Keloth Nayanar Sobhith Velandi Kunnummal Satheesan Balasubramanian Deepak Roshan Valiyaparambil Gopi Source Type: research
